Catalytic Asymmetric Synthesis

The development of chiral catalysts by William Knowles, Ryoji Noyori, and K. Barry Sharpless revolutionized pharmaceutical manufacturing by enabling the selective production of single mirror-image molecules. Sharpless's asymmetric epoxidation achieves enantiomeric excesses exceeding 99%, a standard that is 30% higher than the typical rival catalytic methods of the 1970s. This innovation, which earned the 2001 Nobel Prize in Chemistry, outperforms Discovery of Oxygen in immediate drug industry value, as it now produces over 80% of new chiral medications with tailored three-dimensional shapes.